Publication | Closed Access

Cost Effectiveness of Direct-Acting Antiviral Therapy for Treatment-Naive Patients With Chronic HCV Genotype 1 Infection in the Veterans Health Administration

Direct-acting Antiviral TherapyViral HepatitisAntiviral TherapyHepatitisVirologyCost EffectivenessChronic Viral InfectionAntiviral DrugMedicineVeterans Health Administration